Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Clenbuterol for skeletal muscle glucose uptake in healthy men
NL-OMON50072Phase 2Active, not recruiting
- Sponsor
- Maastricht University
- Start
- Jun 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of clenbuterol in type 2 diabetes mellitus (T2DM) (2 arms), sponsored by Maastricht University. Primary endpoint: Insulin-stimulated peripheral glucose disposal. Started Jun 2019; status: active, not recruiting.
02
Drugs
clenbuterol
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NL-OMON50072.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON50072.